RXLive
St. Petersburg, US · Founded 2018 · 4 known investors
Find your way into RXLive
Sign up to find every way you can get introduced to RXLive
- Your email: who you already know at RXLive, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the RXLive team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
RxLive provides telehealth pharmacist services, software, and analytics to integrate clinical pharmacists into the healthcare team under a "value-based pharmacy" model. It serves patients, healthcare providers, employers, and payers to reduce medication spending and improve clinical outcomes.
Founders & leadership
Board
Investors · 4
How we know: Axial Capital Partners's portfolio page · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Also in the syndicate · 1
Reported raises · per SEC filings
Form D private placements$10.1M disclosed across 5 rounds · 2018–2022
▶$1.6MraisedSep 2022 · 8 investors · Other TechnologyRule 506(b)
- ELIOT HELLERDirector
- SEAN MCNAMARADirector
- MARK ENGELENExecutive Officer, Director
- LORAINE DAUGHERTYDirector
- KRISTIN GRECODirector
- Offering amount
- $1.6M
- Amount sold
- $1.6M
- Minimum investment
- $25K
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$5MraisedSep 2022 · 6 investors · Other TechnologyRule 506(b)
- MAR ENGELENExecutive Officer, Director
- ELIOT HELLERDirector
- LORAINE DAUGHERTYDirector
- SEAN MCNAMARADirector
- KRISTIN GRECODirector
- Offering amount
- $5M
- Amount sold
- $5M
- Minimum investment
- $100K
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$2MraisedApr 2021 · 24 investors · Other TechnologyRule 506(b)
- KRISTIN GRECODirector
- LORAINE DAUGHERTYDirector
- SEAN McNAMARADirector
- MARK ENGELENExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $2M
- Minimum investment
- $12.5K
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$850KraisedOct 2019 · 6 investors · Other TechnologyRule 506(b)
- Sean McNamaraDirector
- Loraine DaughertyDirector
- Mark EngelenExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $850K
- Minimum investment
- $25K
- First sale
- May 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$600KraisedJun 2018 · 9 investors · Other TechnologyRule 506(b)
- Mark EngelenExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $600K
- Minimum investment
- $25K
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does RXLive do?
- RxLive provides telehealth pharmacist services, software, and analytics to integrate clinical pharmacists into the healthcare team under a "value-based pharmacy" model. It serves patients, healthcare providers, employers, and payers to reduce medication spending and improve clinical outcomes.
- Who are RXLive's investors?
- RXLive's investors include Axial Capital Partners, Dreamit Ventures, SpringTide Ventures.
- How much funding has RXLive raised?
- RXLive has disclosed $10.1M raised across 5 rounds.
- Where is RXLive headquartered?
- RXLive is headquartered in St. Petersburg, US.
